Professional Documents
Culture Documents
Research Center for Gastroenterology & Liver Disease, Shahid Behashti University, M.C. &
*
Tarbiat Modares University, Department of Biostatistics, Iran
263
264
Tumour size
(n=337)
Histology type
(n=734)
Subgroup
Well differentiated
Moderately
differentiated
Poorly differentiated
<35 mm
Frequency
n
%
112
24.6
140
30.8
203
93
44.6
27.6
>35 mm
244
72.4
Adenocarcinoma
NOS
Signet cell car. &
mucin-producing
adeno. & mucinous
adeno.
Other type of
histology
T1
532
72.5
72
9.8
130
17.7
18
3.2
T2
70
12.3
T3
260
45.9
T4
219
38.6
130
28.4
263
57.5
64
14.0
Pathologic distant
metastasis (n=506)
Absent
322
63.6
Present
184
36.4
Pathologic stage***
(n=619)
I (0,IAIB)
53
8.6
II
108
17.5
III (IIIA,IIIB)
204
32.9
IV
254
41.0
Extent of wall
penetration*
(n=567)
Age at diagnosis
Sex
Male
1.04 (0.8-1.32)
Female
1.00
Distant metastasis
Absent
1.00
Present
1.01 (0.62-1.61)
Extent of wall penetration
T1
T2
1.24 (0.35-4.35)
T3
2.52 (0.79-8.00)
T4
4.83* (1.53-15.24)
Tumour size
<35 mm
1.00
>35 mm
1.66* (1.40-2.56)
Histology type
Adenocarcinoma
1.00
Signet ring cells &
1.22 (0.91-1.64)
Other
0.95 (0.80-1.129)
Tumour grade
Well differentiated
1.00
Moderately
1.13 (0.73-1.75)
differentiated
Poorly differentiated
1.50* (1.01-2.23)
Lymph node metastasis
N1
1.00
N2
0.98 (0.70-1.34)
N3
1.02 (0.72-1.45)
Pathologic stage
Early
1.00
Advanced
1.84* (1.41-2.41)
Log normal
HR (CI: 95%)
1.02* (1.01-1.03)
0.92 (0.70-1.22)
1.00
1.00
2.14* (1.60-2.86)
2.44* (1.85-3.12)
1.53* (1.16-2.02)
2.92* (1.78-4.81)
1.00
2.19* (1.33-3.60)
1.00
0.79 (0.58-1.06)
1.06 (0.90-1.26)
1.00
1.47* (1.06-2.00)
1.27* (0.90-1.80)
1.00
0.96 (0.69-1.32)
1.09 (0.76-1.55)
1.00
2.08* (1.56-2.78)
265
Age at diagnosis
Sex
Male
Female
Distant metastasis
Absent
Present
Extent of wall penetration
T1
T2
T3
T4
Tumour size
<35 mm
>35 mm
Histology type
Adenocarcinoma
Signet ring cell &
Other
Tumour grade
Well differentiated
Moderately differentiated
Poorly differentiated
Lymph node metastasis
N1
N2
N3
Pathologic stage
Early
Advanced
Full Model
AIC=905.7
1.01 (0.99-1.03)
Log normal
HR (CI: 95%)
Final Model
AIC=2394.2
1.02* (1.00-1.03)
Full Model
AIC=467.3
0.99 (0.98-1.01)
Final Model
AIC=1055.24
1.03 (0.62-1.69)
1.00
1.02 (0.64-1.61)
1.00
1.00
1.38 (0.67-2.85)
1.00
2.09* (1.7-3.20)
1.00
2.02* (1.14-3.53)
1.00
6.67* (1.56-33.33)
4.76* (1.15-20.00)
2.27 (0.5-11.11)
1.00
1.00
8.97* (1.16-69.39)
6.18 (0.83-45.87)
2.86 (0.36-22.91)
1.00
4.08* (2.42-6.88)
2.03* (1.18-3.49)
1.00
0.50 (0.19-1.34)
1.00
11.82* (4.35-32.14)
1.00
1.20 (0.88-1.64)
1.00
5.92* (3.00-11.70)
41.68* (11.02-156.02)
1.00
0.39 (0.81-2.41)
1.00 (0.56-1.78)
1.00
0.87 (0.52-1.46)
1.11 (0.65-1.87)
1.00
1.44 (0.68-3.03)
2.06 (0.92-4.60)
1.00
1.31 (0.70-2.50)
1.64 (0.81-3.33)
1.00
1.51 (0.80-2.84)
1.00
1.51 (0.83-2.78)
4.00* (1.29-6.67)
2.04* (1.28-3.22)
1.00
3.67* (3.06-4.39)
16.28* (11.59-22.65)
266
6.
7.
8.
9.
References
1.
2.
3.
4.
5.
267
29. Kim DY, Park YK, Joo JK, Ryu SY, Kim YJ, Kim SK, et
al. Clinicopathological characteristics of signet ring cell
carcinoma of the stomach. ANZ J Surg 2004; 74 : 1060-4.
30. Nardi A, Schemper M. Comparing Cox and parametric models
in clinical studies. Stat Med 2003; 22 : 3597-610.
Reprint requests: Dr Bijan Moghimi-Dehkordi, Research Center for Gastroenterology & Liver Disease, 7th floor of Taleghani Hospital
Tabnak Street, Evin, Tehran, Iran
e-mail: b_moghimi_de@yahoo.com; Aminphg@gmail.com